Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Activin type II receptors are transmembrane protein-serine/threonine kinases. By using a reverse-transcription PCR assay to screen for protein kinase sequences, we isolated a cDNA clone, activin X1 receptor, from rat brain that encodes a 55-kDa transmembrane protein-serine kinase which is structurally related to other receptors in this kinase subfamily. The predicted protein consists of 509 amino acids, and the kinase domain shows 40% and 37% identity to the activin and transforming growth factor beta type II receptors, respectively. No activin-binding was observed when activin X1 receptor was expressed alone in COS-M6 cells; however, coexpression with type II activin receptors gave rise to a 68-kDa affinity-labeled complex in addition to the 85-kDa type II receptor complex. The size of this cross-linked band is consistent with the size of the type I activin receptor; furthermore, activin X1 receptor associated with type II receptors, as judged by coimmunoprecipitation with type II receptor antibodies. These data suggest that activin X1 receptor can serve as an activin type I receptor and that the diverse biological effects of activins may be mediated by a complex formed by the interaction of two transmembrane protein-serine kinases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation.
Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., & Massague, J. (1990) · Cell · doi:10.1016/0092-8674(90)90251-9 · Cited by 797
Cited by
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
The Bone Morphogenetic Protein System In Mammalian Reproduction
Shimasaki, S., Moore, R. K., Otsuka, F., & Erickson, G. F. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0007 · Cited by 741
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., & Miyazono, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32506-1 · Cited by 730
BMP type I receptor inhibition reduces heterotopic ossification
Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1888 · Cited by 634
Cloning and characterization of a human type II receptor for bone morphogenetic proteins.
Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C. H., & Miyazono, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7632 · Cited by 550
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H., & Miyazono, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.217 · Cited by 496
Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2
Macı́as-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M., & Wrana, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25628 · Cited by 476
Derynck, R., & Feng, X.-H. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00017-6 · Cited by 415
Cárcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., & Massagué, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3810-3821.1994 · Cited by 71
Characterization and Cloning of a Receptor for BMP-2 and BMP-4 from NIH 3T3 Cells
Koenig, B. B., Cook, J. S., Wolsing, D. H., Ting, J., Tiesman, J. P., Correa, P. E., Olson, C. A., Pecquet, A. L., Ventura, F., Grant, R. A., et al. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5961 · Cited by 366
Specific Interaction of Type I Receptors of the TGF-β Family with the Immunophilin FKBP-12
Wang, T., Donahoe, P. K., & Zervos, A. S. (1994) · Science · doi:10.1126/science.7518616 · Cited by 331
Yamashita, H., ten Dijke, P., Franzén, P., Miyazono, K., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32142-7 · Cited by 326
Activation of Signalling by the Activin Receptor Complex
Attisano, L., Wrana, J. L., Montalvo, E., & Massagué, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1066 · Cited by 316
“include the type I receptors ActR-I, ActR-IB, and TSR-I (3, 7, 13, 19, 34, 47, 48 ) and the type II receptors ActR-II and ActR-IIB (4, 31, 33).”
Activin Receptors and Cellular Signaling by the Receptor Serine Kinase Family
MATHEWS, L. S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-310 · Cited by 260
Self-citationDetermination of Type I Receptor Specificity by the Type II Receptors for TGF-β or Activin
Ebner, R., Chen, R.-H., Lawler, S., Zioncheck, T., & Derynck, R. (1993) · Science · doi:10.1126/science.8235612 · Cited by 253
Feijen, A., Goumans, M. J., van den, A. J. M., & Raaij, E.-V. (1994) · Development · doi:10.1242/dev.120.12.3621 · Cited by 252
Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors
Dijke, P. T., Miyazono, K., & Heldin, C.-H. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80058-5 · Cited by 250
The types II and III transforming growth factor-beta receptors form homo-oligomers.
Henis, Y. I., Moustakas, A., Lin, H. Y., & Lodish, H. F. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.139 · Cited by 205
“TGF-/3RII is a transmembrane serine/threonine kinase (Lin et al., 1992; Wrana et al., 1992; Tsuchida et al., 1993a).”
Tsuchida, K., Arai, K. Y., Kuramoto, Y., Yamakawa, N., Hasegawa, Y., & Sugino, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006114200 · Cited by 192
Self-citationCardiac outflow tract defects in mice lacking ALK2 in neural crest cells
Kaartinen, V., Dudas, M., Nagy, A., Sridurongrit, S., Lu, M. M., & Epstein, J. A. (2004) · Development · doi:10.1242/dev.01214 · Cited by 182
“Although ALK2 is also able to bind activin in vitro (Attisano et al., 1993; Tsuchida et al., 1993), it cannot transduce activin-like signals under physiological conditions (Chen et al., 1997; Suzuki et al., 1997a; Macias-Silva et al., 1998).”
BackgroundParks, W. T., Frank, D. B., Huff, C., Renfrew Haft, C., Martin, J., Meng, X., de Caestecker, M. P., McNally, J. G., Reddi, A., Taylor, S. I., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100606200 · Cited by 113
cDNA cloning and expression of human activin βE subunit
Hashimoto, O., Tsuchida, K., Ushiro, Y., Hosoi, Y., Hoshi, N., Sugino, H., & Hasegawa, Y. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00157-0 · Cited by 54
Goebel, E. J., Aykul, S., Hom, W. W., Saotome, K., Economides, A. N., Franklin, M. C., & Idone, V. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502788122 · Cited by 2
Metadata
- Authors
- Tsuchida, K., Mathews, L. S., & Vale, W. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-12
- Volume
- 90
- Issue
- 23
- Pages
- 11242-11246
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2043278825
- Cited by
- 123
- References
- 1
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.